Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center.
Vallome G, Cafaro I, Bottini A, Dellepiane C, Rossi G, Bennicelli E, Parisi F, Zullo L, Tagliamento M, Ballestrero A, Barisione E, Piroddi IMG, Montecucco F, Carbone F, Pronzato P, Lambertini M, Spagnolo F, Barletta G, Barcellini L, Ferrante M, Nardin S, Coco S, Marconi S, Zinoli L, Moscatelli P, Arboscello E, Del Mastro L, Bellodi A, Genova C. Vallome G, et al. Among authors: zinoli l. Heliyon. 2023 Oct 19;9(11):e21177. doi: 10.1016/j.heliyon.2023.e21177. eCollection 2023 Nov. Heliyon. 2023. PMID: 37928020 Free PMC article.
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives.
Cella E, Zullo L, Marconi S, Rossi G, Coco S, Dellepiane C, Alama A, Rozeboom L, Bennicelli E, Parisi F, Sacco G, Barletta G, Zinoli L, Tagliamento M, Pronzato P, Genova C. Cella E, et al. Among authors: zinoli l. Expert Opin Biol Ther. 2022 Oct;22(10):1259-1273. doi: 10.1080/14712598.2022.2116273. Epub 2022 Aug 28. Expert Opin Biol Ther. 2022. PMID: 35994596 Review.
Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy.
Grottoli M, Carrega P, Zullo L, Dellepiane C, Rossi G, Parisi F, Barletta G, Zinoli L, Coco S, Alama A, Marconi S, Parodi M, Orecchia P, Bassi S, Vitale M, Mingari MC, Pfeffer U, Genova C, Pietra G. Grottoli M, et al. Among authors: zinoli l. Cancers (Basel). 2022 Oct 14;14(20):5046. doi: 10.3390/cancers14205046. Cancers (Basel). 2022. PMID: 36291830 Free PMC article. Review.
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes.
Cavo A, Rubagotti A, Zanardi E, Fabbroni C, Zinoli L, Di Meglio A, Arboscello E, Bellodi A, Spallarossa P, Cattrini C, Messina C, Boccardo F. Cavo A, et al. Among authors: zinoli l. Ther Adv Med Oncol. 2018 Jan 9;10:1758834017745819. doi: 10.1177/1758834017745819. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29383035 Free PMC article.
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer.
Cattrini C, Barboro P, Rubagotti A, Zinoli L, Zanardi E, Capaia M, Boccardo F. Cattrini C, et al. Among authors: zinoli l. Transl Oncol. 2020 Jul;13(7):100789. doi: 10.1016/j.tranon.2020.100789. Epub 2020 May 14. Transl Oncol. 2020. PMID: 32416542 Free PMC article.
Prognostic value of nuclear matrix protein expression in localized prostate cancer.
Ricci F, Rubagotti A, Zinoli L, Mangerini R, Nuzzo PV, Carmignani G, Simonato A, Barboro P, Balbi C, Boccardo F. Ricci F, et al. Among authors: zinoli l. J Cancer Res Clin Oncol. 2012 Aug;138(8):1379-84. doi: 10.1007/s00432-012-1216-0. Epub 2012 Apr 10. J Cancer Res Clin Oncol. 2012. PMID: 22488172
16 results